A Low-Cost Generic Cervical Cancer Vaccine Made with Microalgae

Cervical cancer is a leading cause of cancer mortality among women, with more than 85% of the deaths occurring in low- and middle-income countries. Effective commercial vaccines against cervical cancer exist but are expensive. These innovators, linked with McMaster University, will use microalgae to produce vaccines against cervical cancer that cost less than $1 CAD per dose.

Grant ID
ST-POC-0616-01-10
Show on Hub
On
Show on Spoke
Off
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
112000.00
Funding Currency
CAD
Exchange Rate (at time of payment)
0.7500000000
Funding Amount (in USD)
84000.00
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
84000.00
Co-Funded
False